[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover […]
Tag: LLP
Contact Levi & Korsinsky by October 1, 2024 Deadline to Join Class Action Against Indivior PLC(INDV)
[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover […]
Roche’s PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give Tough Competition to AstraZeneca and Other Pharma Companies
[ad_1] Following achievements in Asia, Roche’s PNH treatment drug PIASKY (crovalimab) received its first FDA approval. This approval has spiked the competition between Roche and current market leader AstraZeneca. Additionally, the other pharma companies also […]
NRG Fusion Market to Grow at a CAGR of 15% Due to Expected First Launch of Merus’ Zenocutuzumab and Increased Adoption of NRG1 Fusion Biomarker Testing During the Study Period (2020-2034)
[ad_1] According to DelveInsight’s analysis, the growth of the NRG Fusion market is expected to be mainly driven by the expected launch of various emerging therapies, including zenocutuzumab, HMBD-001, JK07, and others along with increased […]
Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030
[ad_1] The increasing demand for cancer monoclonal antibodies is mainly driven by the rising incidence of cancer, the growing prevalence of risk factors like smoking, radiation exposure, unhealthy lifestyles, and other contributing factors. Additionally, the […]
